CAMLINFINE — Camlin Fine Sciences Share Price
0.000.00%
Last trade - 00:00- IN₹31.29bn
- IN₹37.69bn
- IN₹16.13bn
- 57
- 15
- 100
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.5 | ||
| PEG Ratio (f) | 0.32 | ||
| EPS Growth (f) | 447.39% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.54 | ||
| Price to Tang. Book | 5.25 | ||
| Price to Free Cashflow | 31.3 | ||
| Price to Sales | 1.89 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.04% | ||
| Return on Equity | -26.39% | ||
| Operating Margin | -8.78% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 10,491.48 | 11,871.03 | 14,120.89 | 16,815.64 | 16,130.62 | 17,120 | 19,724 | 12.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +5578.34 | +47.36 | +24.05 | -18.43 | n/a | n/a | +447.39 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Camlin Fine Sciences Limited is an India-based company, which is engaged in research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The Company manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. The Company’s products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care.
Directors
- Ashish Dandekar CHM (52)
- Dattatraya Puranik CFO
- Mondor Godbole CCO
- Rahul Sawale CCO
- Arjun Dukane EDR (51)
- Sarvjit Bedi NED
- Anagha Dandekar NED
- Ajit Deshmukh NED
- Nirmal Momaya NED (49)
- Sutapa Banerjee IND
- Joseph Dsouza NID
- Pradip Kanakia NID
- Atul Pradhan NID
- Thomas Videbaek NID (60)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 30th, 1993
- Public Since
- January 20th, 2015
- No. of Shareholders
- 59,547
- No. of Employees
- 636
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 187,921,012
- Address
- Plot No F/11 & F/12,Wicel Compound, MUMBAI, 400098
- Web
- https://www.camlinfs.com/
- Phone
- +91 2267001000
- Auditors
- Kalyaniwalla & Mistry LLP
Upcoming Events for CAMLINFINE
Camlin Fine Sciences Ltd Annual Shareholders Meeting
Q1 2026 Camlin Fine Sciences Ltd Earnings Release
Similar to CAMLINFINE
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
What is the Camlin Fine Sciences share price?
As of Today at 19:44 UTC, shares in Camlin Fine Sciences are trading at IN₹166.53. This share price information is delayed by 15 minutes.
How has the Camlin Fine Sciences share price performed this year?
Shares in Camlin Fine Sciences last closed at IN₹166.53 and the price had moved by +55.94% over the past 365 days. In terms of relative price strength the Camlin Fine Sciences share price has outperformed the S&P BSE 100 Index by +46.9% over the past year.
What are the analyst and broker recommendations for Camlin Fine Sciences?
The overall consensus recommendation for Camlin Fine Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Camlin Fine Sciences dividend yield?
Camlin Fine Sciences does not currently pay a dividend.
Does Camlin Fine Sciences pay a dividend?
Camlin Fine Sciences does not currently pay a dividend.
When does Camlin Fine Sciences next pay dividends?
Camlin Fine Sciences does not currently pay a dividend.
How do I buy Camlin Fine Sciences shares?
To buy shares in Camlin Fine Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Camlin Fine Sciences?
As of the previous close price of IN₹166.53, shares in Camlin Fine Sciences had a market capitalisation of IN₹31.29bn.
Where are Camlin Fine Sciences shares listed?
Here are the trading details for Camlin Fine Sciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: CAMLINFINE
What kind of share is Camlin Fine Sciences?
Based on an overall assessment of its quality, value and momentum Camlin Fine Sciences is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Camlin Fine Sciences share price forecast for 2025?
The analyst consensus target price for shares in Camlin Fine Sciences is IN₹153.62. That is 7.75% below the last closing price of IN₹166.53.
Analysts covering Camlin Fine Sciences currently have a consensus Earnings Per Share (EPS) forecast of IN₹1.15 for the next financial year.
Find out moreWhat is the trend in the Camlin Fine Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Camlin Fine Sciences. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +80.25%.
As of the last closing price of IN₹166.53, shares in Camlin Fine Sciences were trading +34.2% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Camlin Fine Sciences PE Ratio?
The Camlin Fine Sciences PE ratio based on its reported earnings over the past 12 months is 26.5. The shares last closed at IN₹166.53.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Camlin Fine Sciences?
Camlin Fine Sciences' management team is headed by:
- Ashish Dandekar - CHM
- Dattatraya Puranik - CFO
- Mondor Godbole - CCO
- Rahul Sawale - CCO
- Arjun Dukane - EDR
- Sarvjit Bedi - NED
- Anagha Dandekar - NED
- Ajit Deshmukh - NED
- Nirmal Momaya - NED
- Sutapa Banerjee - IND
- Joseph Dsouza - NID
- Pradip Kanakia - NID
- Atul Pradhan - NID
- Thomas Videbaek - NID